Evidence map›Paper›PMID 23022220›Full record

ArticleNeuroscience2013

The interaction of disrupted type II neuregulin 1 and chronic adolescent stress on adult anxiety- and fear-related behaviors.

S B Taylor, A R Taylor, J I Koenig

Abstract read
In one paragraph

Article in Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Sexual Dimorphism in Glucocorticoid Stress Response.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. A NewScientifica · 2018
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

S B TaylorProgram in Neuroscience, University of Maryland School of Medicine, Baltimore, MD 21201, USA. SaraTaylor@asu.edu
A R Taylor
J I Koenig
University of Maryland, Baltimore · US

Funding

Tretment of negative symptoms and cognitive impairment in schizopreniaP50MH082999 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI CARPENTER, WILLIAM T. · 2008 to 2012
$9.7M
Neuropeptide Involvement In Male Social BehaviorR01MH073826 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI KOENIG, JAMES I · 2006 to 2009
$978k
NIDA NIH HHS N01 DA059909NIMH NIH HHS P50 MH082999NIMH NIH HHS P50MH82999NIMH NIH HHS R01 MH073826NIMH NIH HHS R01MH73826
6 · The paper itself

Abstract

The incidence of anxiety, mood, substance abuse disorders and schizophrenia increases during adolescence. Epidemiological evidence confirms that exposure to stress during sensitive periods of development can create vulnerabilities that put genetically predisposed individuals at increased risk for psychiatric disorders. Neuregulin 1 (NRG1) is a frequently identified schizophrenia susceptibility gene that has also been associated with the psychotic features of bipolar disorder. Previously, we established that Type II NRG1 is expressed in the hypothalamic-pituitary-adrenal (HPA) axis neurocircuitry. We also found, using a line of Nrg1 hypomorphic rats (Nrg1(Tn)), that genetic disruption of Type II NRG1 results in altered HPA axis function and environmental reactivity. The present studies used the Nrg1(Tn) rats to test whether Type II NRG1 gene disruption and chronic stress exposure during adolescence interact to alter adult anxiety- and fear-related behaviors. Male and female Nrg1(Tn) and wild-type rats were exposed to chronic variable stress (CVS) during mid-adolescence and then tested for anxiety-like behavior, cued fear conditioning and basal corticosterone secretion in adulthood. The disruption of Type II NRG1 alone significantly impacts rat anxiety-related behavior by reversing normal sex-related differences and impairs the ability to acquire cued fear conditioning. Sex-specific interactions between genotype and adolescent stress also were identified such that CVS-treated wild-type females exhibited a slight reduction in anxiety-like behavior and basal corticosterone, while CVS-treated Nrg1(Tn) females exhibited a significant increase in cued fear extinction. These studies confirm the importance of Type II NRG1 in anxiety and fear behaviors and point to adolescence as a time when stressful experiences can shape adult behavior and HPA axis function.

Indexed as

Adrenal GlandsAge FactorsAnimalsAnxietyChronic DiseaseFearFemaleHypothalamusMaleNeuregulin-1Pituitary GlandRatsRats, Inbred F344Rats, TransgenicNeuregulin-1Nrg1 protein, ratAMGamygdalaanalysis of varianceANOVAchronic variable stressCONcontrolCORTcorticosteroneCVSEDTAelevated plus mazeEPMethylenediaminetetraacetic acidfear conditioningGCglucocorticoidglucocorticoid receptorGRHPAHPA axishypothalamic–pituitary–adrenalknock outKOmineralocorticoid receptorMRneuregulinneuregulin 1NRG1open-to-total ratioOTRreactivitysex differenceTMtransmembranewild typeWT

Identifiers

PMID23022220
PMCPMC3568180
OpenAlexW2053262182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.